ALBERTDAVDNSEAlbert David Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 13 May, 2025 · 19:07 IST

Albert David Limited has informed the Exchange about General Updates appointment of MKB & Associates as Secretarial Auditors for a period of 5 years subject to approval at 86th AGM.

Revenue DeclineEbitda Margin CompressionNegative Operating CashflowResults View source PDFExplain this filing

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-6.3%Reaction day
₹882.10
prior close
₹840.05
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.6%-7.9% vs market
Pharmaceuticals peers, median of 150sector+1.0%-7.3% vs sector

On the reaction day the stock moved 7.9 pts less than Nifty Microcap 250 and 7.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.9
10m
-1.0
15m
-1.2
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-6.3+1.6-7.9+1.0-7.3
Next day
-6.3+2.6-9.0+1.7-8.0
2d
-6.2+3.4-9.6+1.9-8.1
3d
-6.4+4.7-11.0+3.2-9.6
4d
-7.4+3.6-10.9+2.3-9.6
5d
-7.8+4.4-12.2+2.9-10.7
1w
-8.2+4.9-13.1+2.4-10.5
15d
-9.5+6.8-16.3+3.5-13.1
1m
-2.5+8.4-10.9+3.6-6.1
2m
+7.7+10.0-2.3+5.7+1.9
3m
-8.4+4.7-13.1+2.9-11.3
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Albert David Limited reported a sharp decline in FY25 profitability alongside routine auditor changes and a final dividend declaration. Revenue from operations fell to Rs. 34,576.80 lacs from Rs. 36,246.17 lacs in FY24, a ~4.6% drop, while other income halved to Rs. 2,958 lacs. Profit before tax plunged 74% to Rs. 2,522.77 lacs, and PAT dropped ~77% to Rs. 1,720.08 lacs (EPS of Rs. 30.14 vs Rs. 132.15 prior year). Q4 FY25 alone swung to a loss of Rs. 1,032.79 lacs versus a Rs. 1,291 lacs profit a year ago. The Board recommended a Rs. 5/share final dividend (50%) subject to AGM approval, and reappointed PwC as Internal Auditor and S. Gupta & Co. as Cost Auditor, while appointing MKB & Associates as Secretarial Auditor for 5 years. Statutory auditors L. B. Jha & Co. issued an unmodified opinion.

Likely market impact

A steep ~77% fall in full-year PAT and a swing to a Q4 loss signal significant margin pressure and weakening earnings momentum, likely weighing on near-term sentiment despite the unchanged dividend payout. The negative operating cash flow of Rs. 2,844 lacs (vs Rs. 4,550 lacs generated last year) and a near-depletion of cash balances to Rs. 41.73 lacs raise liquidity concerns worth monitoring.